Should I buy UiPath (PATH) stock or is it too late?
⭐ The most reliable of them, either direction: RBC Capital — 64% of its targets hit on this sector (137 calls tested). It aims for $15 (-18 %), call made on August 15, 2026, maturing on August 15, 2027 (13 d ago).
Firm-by-firm track record on UiPath
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 50 % | +4.5 % | 8 | $13 -29% |
| Truist Securities | 43 % | -16.3 % | 7 | $12 -35% |
| Canaccord Genuity | 33 % | -20.7 % | 6 | $15 -18% |
| Needham | 30 % | -20.8 % | 10 | $15 -18% |
| Credit Suisse | 57 % | +5.2 % | 7 | — |
✅ Reasons to believe
- Few solid positives from analysts right now: of 12 ratings, only 2 buys, and the median price target ($13) is -29% below the price ($18). Caution prevails.
⚠️ Reasons to hesitate
- Even the most reliable firm on PATH, Wells Fargo (50% hit rate, 8 scored calls), only targets $13 (call made on March 12, 2026, maturing on March 12, 2027) (-29%) in its most recent call, and $14 (call made on December 4, 2025, maturing on December 4, 2026) (-24%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 12 ratings, 9 are neutral and 1 is a sell.
- Limited upside: the median target is only -29% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on PATH
Median target $13 (-29%) · 12 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in UiPath now?
We won't decide for you. The facts: 17% of analysts rate it a buy, median target $13 (-29%), and Wells Fargo (most reliable on PATH, 50%) targets $13. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in UiPath?
The stated upside is small: the median target ($13) sits just -29% from the price ($18) (most reliable on PATH: Wells Fargo, 50%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is UiPath still worth investing in?
It depends on the gap between the price ($18) and its estimated value: analysts target $13 on median (-29%), with 17% buys (most reliable on PATH: Wells Fargo, 50%). Cross-check with their real reliability on PATH and the cautions above. Information, not advice.
What's the main risk in buying PATH?
Even the most reliable firm on PATH, Wells Fargo (50% hit rate, 8 scored calls), only targets $13 (call made on March 12, 2026, maturing on March 12, 2027) (-29%) in its most recent call, and $14 (call made on December 4, 2025, maturing on December 4, 2026) (-24%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full UiPath profile (consensus, analyst reliability, price target, performance).